Zometa May Have Direct Effect on Breast Tumors
 

http://www.curetoday.com/index.cfm/f...article_id/900

"Adding Zometa (zoledronic acid) to chemotherapy before surgery led breast tumors to shrink by an additional third, according to a subset analysis of the AZURE trial. This is the first patient-related direct evidence that Zometa, a bisphosphonate drug used to treat cancer-related bone loss, has an anti-tumor effect, said study investigator Robert Coleman, MD, of the University of Sheffield in the United Kingdom."